Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.6K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.6K
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
Clinical Trials01:16

Clinical Trials

10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Letrozole Alters Transcriptomic Profiles in Infrapatellar Fat Pad From Female Mice: Possible Involvement of Interleukins in Aromatase Inhibitor-Induced Arthralgias.

Journal of applied toxicology : JAT·2026
Same author

Machine learning-enabled diagnosis of viral respiratory infections from exhaled volatile organic compound analysis.

BMC pulmonary medicine·2026
Same author

Special issue on dose optimization.

Journal of biopharmaceutical statistics·2026
Same author

An Anti-Inflammatory and Pro-Angiogenic Porous Aloe Polysaccharide-Collagen Dressing Accelerates Wound Healing.

ACS applied bio materials·2025
Same author

M-DODII: Bayesian dose optimization design for randomized phase II study with multiple indications.

Journal of biopharmaceutical statistics·2025
Same author

Fruquintinib in less pretreated patients: Multivariate profile-matching analysis of FRESCO-2 to FRESCO.

European journal of cancer (Oxford, England : 1990)·2025

相关实验视频

Updated: Feb 19, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.9K

对于整体临床试验监测的假设无神论深度学习框架.

Shaoming Yin1,2, Zheyang Wu3,4, Jianchang Lin5

  • 1Takeda Pharmaceuticals, Cambridge, MA, USA. shaoming.yin@takeda.com.

Therapeutic innovation & regulatory science
|February 17, 2026
PubMed
概括
此摘要是机器生成的。

这项研究引入了一个假设无意识的机器学习框架,用于在临床试验中检测异常,改善质量耐受性限制监测和参与者安全.

关键词:
异常检测检测异常检测自动编码器自动编码器临床试验中的临床试验.深度学习是一种深度学习.长期短期记忆 长期短期记忆基于风险的监测是基于风险的监测.

相关实验视频

Last Updated: Feb 19, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.9K

科学领域:

  • 临床数据科学临床数据科学
  • 机器学习在医疗保健中的应用
  • 监管科学是一种监管科学.

背景情况:

  • 目前的机器学习 (ML) 方法用于临床试验中的质量容忍限度 (QTL) 监测具有局限性.
  • 其中包括依赖参数假设,数据类型限制 (Poisson/Bernoulli) 和将访问视为独立的处理,阻碍复杂试验的性能.

研究的目的:

  • 为在临床试验中检测异常提出一种新的,不依据假设的框架.
  • 为了在各种数据类型和层次上实现持续的,集中检测异常,包括QTL偏差.

主要方法:

  • 一个分层的,非参数的,多维的偏差评分方案.
  • 一个长时间的短期记忆自编码器来学习数值变量的联合时间分布.
  • 摄入来自各种来源的流数据,推断出没有预定义映射的共享隐性多元体.

主要成果:

  • 该框架在异常信号歧视方面取得了实质性的改进.
  • 它显著减少了不必要的后续工作,并显示出强大的计算可扩展性.
  • 通过基于真实世界的试验数据和异常模式的模拟进行评估.

结论:

  • 拟议的框架为早期危险检测和加强参与者安全提供了一个实用的工具.
  • 它与基于风险的监测模式 (ICH E6 (R3)) 保持一致.
  • 通过先进的异常检测,实现了简化临床试验操作.